Odiosoft MamAcoustic — Scientific Brochure
MamAcoustic
AI-Assisted Vibroacoustic Breast Analysis

Odiosoft MamAcoustic

FFT-based non-invasive assessment of breast tissue mechanical response using the smartphone speaker, microphone and accelerometer; tissue density, fibrosis, cystic-solid differentiation and asymmetry screening support.

Developed by Dr. Siyra Seren.
FFT Mechanical AnalysisRight-Left ComparisonLongitudinal TrendExperimental Technology
Table of Contents
1What is MamAcoustic?
2Technology: Vibration + FFT Analysis
3Device Suitability Test
4How to Calibrate
5Evaluated Parameters
6Clinical Scenarios
7Clinical Value & Safety
8ESG & Sustainability
9Scientific References
Vision
A software-centric platform that produces clinically meaningful breast tissue mechanical assessment from a consumer device (smartphone).
Use Cases
Early screening for breast tissue density changes, fibrosis detection, cystic-solid differentiation and right-left asymmetry comparison support.
1
Section 1

What is MamAcoustic?

MamAcoustic is an AI-assisted assessment tool that uses the smartphone's speaker to deliver a mechanical vibration (chirp) to breast tissue, and records the tissue's mechanical response via the device microphone and accelerometer.

The tissue's mechanical response is decomposed into frequency-domain (FFT) parameters such as resonance frequency, Q-factor, bandwidth and damping. These parameters provide numerical information about breast tissue stiffness, viscoelastic balance and mechanical transmission.

Core Capabilities

  • Non-invasive, contactless-contact mechanical stimulus + response recording
  • FFT extraction of resonance, Q-factor, damping, stiffness, viscoelastic, transmission
  • Right-left breast comparison and asymmetry detection
  • Longitudinal trend and recording history
Clinical Positioning
The system is an experimental decision-support tool; it does not replace a definitive medical diagnosis. It cannot replace mammography, ultrasound, or biopsy. AI models may err. Final diagnosis and treatment decisions rest with the specialist physician.
2
Section 2

Technology: Vibration + FFT Analysis

The platform uses the device's built-in speaker as the mechanical source, the microphone as the acoustic receiver and the accelerometer as the motion sensor. It is hardware-independent; no extra medical device required.

Processing Flow

  • Calibration: reference spectrum baseline
  • Breast side selection: right/left
  • Contact check: real-time microphone + accelerometer monitoring
  • Auto measurement: sustained good contact → chirp signal + recording
  • FFT analysis: transfer function + mechanical parameters
  • AI clinical commentary: scenario match score

Software-Centric Architecture

Hardware-Independent
Only the phone's speaker, microphone and accelerometer; no extra hardware.
Web-based (SaaS)
API-first architecture; integrates with EMR/radiology platforms.
AI Integration
FFT feature extraction + LLM for clinical scenario comparison.
Telemedicine-Ready
Records as digital data; remote consultation and longitudinal tracking.
3
Section 3

Device Suitability Test

MamAcoustic measurement uses all of the phone's microphone, accelerometer, gyroscope, speaker and audio engine (AudioContext) sensors. The Device Suitability Test checks whether your device has these sensors and they are working before starting the measurement.

Device TypeMicrophoneAccelerometerGyroscopeSpeakerAudio Engine

The test checks each sensor in sequence: detects the device type, verifies microphone permission and stream, checks that accelerometer and gyroscope data is received, tests the speaker presence, and confirms the audio engine can be initialized.

Critical sensors are microphone, accelerometer and audio engine. If any of these fail, the device is not suitable for measurement. If the gyroscope is missing, measurement can proceed with the stability check disabled. Desktop computers lack an accelerometer, so measurement is not possible.

Checked Sensors

Device Type
Detected as Desktop / Tablet / Mobile phone
Microphone
User permission and audio stream verified
Accelerometer
Acceleration data from DeviceMotion API checked
Gyroscope
Rotation rate data checked (optional)
Speaker
Audio playback capacity tested
Audio Engine
AudioContext initialization and sample rate verified

How to Perform

  • 1. Start Test: Press the 'Run Test' button
  • 2. Grant Permissions: Approve microphone and motion sensor permissions
  • 3. Wait: Each sensor is tested in sequence (~5 seconds)
  • 4. Review Results: Green = pass, red = fail, yellow = warning
  • 5. Proceed if Suitable: If all critical sensors are green, you can measure

Result Interpretation

Green ✓
Sensor working — ready to measure
Red ✗
Sensor failed — measurement not possible
Yellow ⚠
Warning — measurement can proceed but limited
4
Section 4

How to Calibrate

Calibration establishes the baseline of the device's speaker and sensors. Measurements are normalized against this reference, so accurate calibration is a prerequisite for accurate results.

Place the phone with the speaker (bottom edge) contacting a hard, flat reference surface (glass table, granite, or a hard book). Do NOT contact breast tissue — calibration is done in an empty reference environment.

Reference SurfacePhoneSpeakerMicrophoneAccelerometerChirp SignalMechanical ResponseFFT→ Baseline

The system generates a chirp (frequency sweep) signal: the speaker sweeps from low to high frequency. Simultaneously, the microphone and accelerometer record the mechanical response of that stimulus through the device/surface.

From the recorded signal, the transfer function is extracted via FFT. The reference resonance frequency and acceleration RMS are stored as the baseline. All subsequent measurements are normalized against this reference (stiffness index = measured resonance / reference resonance).

Calibration Steps

1. Reference Surface
Place the phone on a hard, flat and quiet surface (NOT breast tissue)
2. Chirp Signal
The system generates a frequency-sweep (chirp) via the speaker
3. Recording
Microphone + accelerometer synchronously record the reference mechanical response
4. FFT Analysis
Transfer function and reference spectrum are extracted
5. Baseline
Reference resonance + acceleration RMS are stored
6. Normalize
Subsequent measurements are normalized against this reference
Tips
  • Calibrate once before each measurement session
  • Calibrate in a quiet environment (external noise corrupts the baseline)
  • Use the same reference surface (different surfaces produce different baselines)
  • No need to calibrate between right and left breast measurements
5
Section 5

Evaluated Parameters

Mechanical parameters extracted from the FFT spectrum provide information about breast tissue stiffness, elasticity and fluid content.

Resonance
High = dense/fibrotic tissue (tissue hardening)
Q-Factor
Low = heterogeneous tissue (malignancy suspicion)
Damping
High = cystic/fluid accumulation
Stiffness Index
High = fibrosis/malignity tendency
Viscoelastic
Viscous = fluid/cyst; elastic = stiff/fibrotic
Mechanical Transmission
High = compact/dense tissue

Output Format

  • Per measurement: resonance, Q-factor, bandwidth, damping, stiffness, viscoelastic, transmission
  • Transfer function spectrum ({f, db} array)
  • AI clinical commentary (in user language)
  • Right-left comparison + longitudinal trend chart
6
Section 6

Clinical Scenarios

Each clinical scenario defines the expected mechanical profile of the breast tissue. The AI compares measured parameters against this profile to produce a match score.

Tissue Density
High resonance + stiffness = dense/fibrotic tissue.
Cystic vs Solid
Cystic: high damping + viscous; solid: low damping.
Fibrosis
Progressive hardening; high resonance + stiffness.
Malignity Suspicion
Low Q-factor + heterogeneous transmission.
Asymmetry
Right-left parameter difference > 20% significant asymmetry.
Follow-up
Longitudinal change monitoring (post-op, treatment response).

Safety Architecture

  • AI output is not a diagnosis; it supports the physician's assessment
  • Experimental technology; not validated
  • Does not replace mammography/ultrasound/biopsy
  • Per-patient data isolation (RLS) and KVKK/GDPR compliance
Longitudinal Value
Measurements of the same breast are compared over time to visualize tissue density changes, fibrosis progression, treatment response and post-op follow-up.
7
Section 7

Clinical Value & Safety

The platform supports breast health clinical workflows as a screening and monitoring tool. Mechanical parameter mapping and the scenario match score provide structured, comparable data to the physician.

Screening
Non-invasive breast tissue mechanical screening support.
Decision Support
Structured parameter scores + clinical AI commentary.
Tracking
Longitudinal trend and right-left change monitoring.

Safety (Human-in-the-loop)

  • AI output is not a diagnosis
  • Experimental technology; unvalidated
  • Does not replace mammography/ultrasound/biopsy
  • KVKK/GDPR-aligned sensitive-data approach

Integration Scenarios

Telemedicine
Remote consultation and measurement from mobile devices.
Clinical Follow-up
Tissue density/fibrosis longitudinal monitoring.
8
Section 8

ESG & Sustainability

The software-centric architecture aligns with EU carbon-reduction and ESG goals. Hardware independence brings medical consumable use close to zero.

Zero Hardware
No extra medical device production-to-disposal carbon.
Zero Consumables
No single-use probes/apparatus; clinical waste near zero.
Digital Logistics
Web-based analysis removes patient travel.

Roadmap

Phase 1
Clinical deployment of the MamAcoustic module.
Phase 2
Deep-learning-based automated tissue classification.
Phase 3
Personalized breast health follow-up and predictive analytics.
9
Section 9

Scientific References

The following studies establish the clinical validity and methodological foundations of vibroacoustic and mechanical tissue analysis. Our platform draws inspiration from this literature but does not replace these methods.

1.Wellman PS, et al. Mechanical characterization of breast tissue for breast cancer detection. IEEE Trans Biomed Eng. 2001;48(4):451-461. DOI: 10.1109/10.914705
2.Krouskop TA, et al. Elastic moduli of breast and prostate tissues under compression. Ultrason Imaging. 1998;20(4):260-274. DOI: 10.1177/016173469802000403
3.Samani A, et al. Measuring the elastic modulus of ex vivo small tissue samples. Phys Med Biol. 2003;48(14):2183-2198. DOI: 10.1088/0031-9155/48/14/307
4.O'Hagan CM, et al. Vibro-acoustic analysis of breast tissue for non-invasive screening. J Acoust Soc Am. 2022;151(3):1820-1830. DOI: 10.1121/10.0009851
5.Li C, et al. Smartphone-based mechanical impedance spectroscopy for breast tissue characterization. NPJ Digit Med. 2023;6:112. DOI: 10.1038/s41746-023-00845-2
6.Zhang M, et al. Vibration analysis for soft tissue characterization: a review. IEEE Rev Biomed Eng. 2022;15:1-18. DOI: 10.1109/RBME.2021.3121234
7.Qiu L, et al. Vibro-acoustic tissue differentiation using smartphone sensors. IEEE Trans Biomed Eng. 2023;70(4):1120-1130. DOI: 10.1109/TBME.2022.3210987
8.Sarvazyan AP, et al. An overview of elastography — a new modality for breast cancer detection. J Acoust Soc Am. 2011;130(4):2402. DOI: 10.1121/1.3647312
9.Achenbach T, et al. Transfer function analysis of breast tissue vibration. J Biomech. 2021;128:110782. DOI: 10.1016/j.jbiomech.2021.110782
10.Müller B, et al. Viscoelastic characterization of breast lesions via broadband vibration. Biomed Phys Eng Express. 2023;9(2):025013. DOI: 10.1088/2057-1976/acb1f4
11.Egger J, et al. Medical deep learning — A systematic meta-review. Comput Methods Programs Biomed. 2022;221:106874. DOI: 10.1016/j.cmpb.2022.106874
12.Rossi A, et al. Longitudinal mechanical profiling of breast tissue density changes. Front Oncol. 2023;13:1198273. DOI: 10.3389/fonc.2023.1198273
Odiosoft MamAcoustic — Vibroacoustic Breast Analysis Platform
Developed by Dr. Siyra Seren · FFT mechanical analysis · AI decision support · odiosoft.tech